Ravat Panvichien

6PUBLICATIONS
3CO-AUTHORS
Cancer geneticsPredictive and prognostic markersMolecular targetsCardiology (incl. cardiovascular diseases)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 02, 2022
Characteristics of breast cancer patients tested for germline BRCA1/2 mutations by next-generation sequencing in Ramathibodi Hospital, Mahidol University.

Songporn Oranratnachai, Watchalawalee Yamkaew, Atchara Tunteeratum

|Mar 21, 2021
PCNA-associated factor (KIAA0101/PCLAF) overexpression and gene copy number alterations in hepatocellular carcinoma tissues.

Anchalee Tantiwetrueangdet, Ravat Panvichian, Pattana Sornmayura

|Mar 20, 2020
HCC-derived EGFR mutants are functioning, EGF-dependent, and erlotinib-resistant.

Natthaporn Sueangoen, Anchalee Tantiwetrueangdet, Ravat Panvichian

|Oct 05, 2018
Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissues.

Anchalee Tantiwetrueangdet, Ravat Panvichian, Sansanee Wongwaisayawan

|Aug 18, 2018
Reduced HBV cccDNA and HBsAg in HBV-associated hepatocellular carcinoma tissues.

Anchalee Tantiwetrueangdet, Ravat Panvichian, Pattana Sornmayura

|Feb 20, 2015
TOP2A amplification and overexpression in hepatocellular carcinoma tissues.

Ravat Panvichian, Anchalee Tantiwetrueangdet, Napat Angkathunyakul

Pageof 1